Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2015-03-20Clinical Trial Update: A Prospective Multi Centre Trial on Bipolar Radiofrequency Ablation of Atrial Fibrillation [NA]
A prospective multi-centre trial evaluating bipolar radiofrequency ablation for atrial fibrillation has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-12-16Clinical Trial Update: Catheter Ablation for Recently Diagnosed Paroxysmal Atrial Fibrillation [Phase 4]
A Phase 4 clinical trial evaluating catheter ablation for recently diagnosed paroxysmal atrial fibrillation has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-12-12Clinical Trial Update: Anticoagulation in AF Ablation and Effects on Neurocognitive Function [Phase 4]
This Phase 4 trial investigating anticoagulation in atrial fibrillation patients undergoing ablation and its effects on neurocognitive funct…
-
CLINICAL_TRIALS withdrawal · 2014-03-20Clinical Trial Update: Prolongation of the Interval Between Prothrombin Time Tests in Stable Patients II [Phase 3]
A Phase 3 trial evaluating prolongation of the interval between prothrombin time tests in stable patients with atrial fibrillation and valvu…
-
CLINICAL_TRIALS withdrawal · 2013-08-26Clinical Trial Update: A Study Comparing Vernakalant Therapy to Amiodarone Therapy in Acute Management of Recent Onset Atrial Fibrillation (AF) (MK-6621-055) [Phase 4]
A Phase 4 study comparing Vernakalant to Amiodarone for the acute management of recent-onset atrial fibrillation was withdrawn from the tria…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2013-06-21Clinical Trial Update: Atrial Fibrillation After Catheter Versus Thoracoscopic Ablation Using Patient Activated Implantable Loop Recorders: The ACTUAL Study [Phase 4]
A Phase 4 clinical trial evaluating atrial fibrillation after catheter versus thoracoscopic ablation using patient-activated implantable loo…
-
CLINICAL_TRIALS withdrawal · 2013-02-25Clinical Trial Update: Study of Left Atrial Appendage Closure in Patients With Atrial Fibrillation - III [Phase 4]
A Phase 4 study evaluating left atrial appendage closure in patients with atrial fibrillation has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-10-17Clinical Trial Update: Catheter Ablation for Atrial Fibrillation and Heart Failure
The trial investigating catheter ablation for atrial fibrillation in patients with heart failure has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-09-03Clinical Trial Update: KONVERT-AF - Relevance of Point in Time for Conversion of Acute Atrial Fibrillation [NA]
The KONVERT-AF trial evaluating the relevance of timing for conversion of acute atrial fibrillation has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-05-07Clinical Trial Update: Comparison of External Event Recorders for Atrial Fibrillation Monitoring [NA]
The clinical trial comparing external event recorders for atrial fibrillation monitoring has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-01-18Clinical Trial Update: Effect of Remote Ischemic Preconditioning on Cardiac Function After Cardiac Surgery [Phase 1]
A Phase 1 clinical trial evaluating remote ischemic preconditioning to improve cardiac function after cardiac surgery has been withdrawn. Th…
-
CLINICAL_TRIALS withdrawal · 2011-02-21Clinical Trial Update: AtriCure Bipolar Radiofrequency Ablation of Persistent Atrial Fibrillation [Phase 3]
A Phase 3 trial evaluating AtriCure's bipolar radiofrequency ablation for persistent atrial fibrillation has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2011-02-21Clinical Trial Update: AtriCure Minimally Invasive Surgical Ablation for Atrial Fibrillation/RESTORE IIB [Phase 2]
A Phase 2 trial evaluating AtriCure's minimally invasive surgical ablation for atrial fibrillation (RESTORE IIB) has been withdrawn.
-
EMA withdrawal · 2009-12-31EMA Withdrawn: Tikosyn (dofetilide) — Pfizer Limited
Tikosyn (dofetilide) has been withdrawn in the EU by Pfizer Limited, with the medicinal product no longer authorized for use.
-
EMA withdrawal · 2006-09-08EMA Application withdrawn: Multaq (dronedarone) — Sanofi-Aventis
EMA withdrew the application for Multaq (dronedarone) for atrial fibrillation/flutter.